Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-16-000813

Director sold 6,467 shares at an average $107.17 ($693,039)

  • Director acquired 6,467 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BAUMGARTNER ROBERT V · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-01 Exercise or conversion : show line 1 in the form +2,387 $65.47 $156,277 8,446 D
2016-09-01 Exercise or conversion : show line 2 in the form +1,467 $66.59 $97,688 9,913 D
2016-09-01 Sale : show line 3 in the form −3,854 $107.18 $413,052 6,059 D
2016-09-02 Exercise or conversion : show line 4 in the form +2,613 $65.47 $171,073 8,672 D
2016-09-02 Sale : show line 5 in the form −2,613 $107.15 $279,987 6,059 D
Open-market sales · 6,467 sh · avg $107.17 · $693,039

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2016-09-01 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −2,387 2,613 D
2016-09-02 Exercise or conversion : show line 7 in the form Stock Option (right to buy) −2,613 0 D
2016-09-01 Exercise or conversion : show line 8 in the form Stock Option (right to buy) −1,467 0 D
Loading xslF345X03/edgar.xml…